VE

Veeva Systems Inc.

VEEVHealthcareNASDAQ

Health Information Services · Last scanned Jul 18, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$3.20B
+16.3% YoY
Net Income
$908.9M
+27.3% YoY
EBITDA
$954.3M
+30.6% YoY
Free Cash Flow
$1.26B

Scan Results

Daily timeframe
12 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 RSI OverboughtRSI 84.5, above 70, stock may be overbought
Jul 10 RSI OverboughtRSI 82.0, above 70, stock may be overbought
About Veeva Systems Inc.

Part of the healthcare sector, Veeva Systems Inc. (VEEV) is listed under Health Information Services. With a market capitalization of $31.74B, it sits in large-cap territory. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands.

Key stats
Market Cap$31.74B
P/E (TTM)34.95
Fwd P/E19.47
EPS$5.59
Beta0.94
52W Change-30.8%
ROE13.9%
Analysis

Veeva Systems Inc. holds $7.31B in cash against $103.1M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Annual free cash flow of $1.26B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 13.9%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 7.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $2.16B (2023) to $3.20B (2026), reflecting a 48% increase over the period.

With cash comfortably exceeding debt, VEEV has financial flexibility that may help navigate uncertain periods. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Veeva Systems Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms